Pfizer Accupril 10mg Tablets Recall: N-Nitrosoquinapril Over Limit
Pfizer recalls Accupril 10mg tablets (NDC 0071-0530-23) due to N-nitrosoquinapril levels exceeding safe limits. This may pose a health risk. Contact Pfizer for details.
Recall notice
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Contact the company
What happened, in plain English
Pfizer is recalling Accupril 10mg tablets (90 tablets) because they contain higher-than-acceptable levels of N-nitrosoquinapril. This could pose a health risk to people taking the medication. Read more at govinfonow.com/recall/34816-pfizer-accupril-10mg-tablets-recall-n-nitrosoquinapril-over-limit.
Source Summary by GovInfoNow · govinfonow.com/recall/34816-pfizer-accupril-10mg-tablets-recall-n-nitrosoquinapril-over-limit · Updated August 18, 2026 · FDA enforcement record: FDA #D-0872-2022
Cite this page
“Pfizer Accupril 10mg Tablets Recall: N-Nitrosoquinapril Over Limit.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34816-pfizer-accupril-10mg-tablets-recall-n-nitrosoquinapril-over-limit. Based on FDA recall #D-0872-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0872-2022%22&limit=1).
Why it’s dangerous
The tablets contain N-nitrosoquinapril in amounts above the acceptable limits. This chemical is a potential carcinogen, which could increase cancer risk with long-term use. The specific health risks are not clearly stated in the recall notice.
Who’s affected
People who have been prescribed Accupril 10mg tablets (NDC 0071-0530-23) by a doctor. Those taking the medication are at risk due to potential health effects from the chemical levels.
How to tell if you have this one
Check if you have Accupril 10mg tablets (90 tablets) with NDC code 0071-0530-23. The product was distributed by Parke-Davis Division of Pfizer Inc. and expired on March 31, 2023.
- Brand
Pfizer- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide and Puerto Rico
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0872-2022 | Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017; Lot: DR9639 Exp. MAR 31 2023 | 2079 bottles |
| D-0873-2022 | Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017; Lots: DX8682 Exp. MAR 31 2023; DG1188 Exp. MAR 31 2022 | 10,304 bottles |
| D-0874-2022 | Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017; Lots: DX6031 Exp. MAR 31 2023; CK6260 Exp. MAY 31 2022 | 8346 bottles |
What to do — step by step
Check Your Medication
Verify if you have Accupril 10mg tablets (90 tablets) with NDC 0071-0530-23.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0872-2022 (April 22, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0872-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.